Showing results (561-570 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|January 13, 2022
A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal MelanomaDavid R Minor, Kevin B Kim, Ricky T Tong, et al.Cancer Biotherapy & Radiopharmaceuticals|March 21, 2019
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer CellsMi Zhang, Siyu Liu, Chenyang Fu, et al.Cancer Biotherapy & Radiopharmaceuticals|March 22, 2021
miR-548b Suppresses Melanoma Cell Growth, Migration, and Invasion by Negatively Regulating Its Target Gene HMGB1Xi-En FengCancer Biotherapy & Radiopharmaceuticals|March 25, 2021
Retrospective Analyses of Complete Resection Combined with Systemic Chemotherapy and Targeted Therapy for Patients with Ovarian Metastases from Colorectal CancerGangling Tong, Qianjiang Luo, Xionghao Pang, et al.Cancer Biotherapy & Radiopharmaceuticals|March 25, 2021
Predictive Value of ERCC1 mRNA Level from Receiver-Operator Characteristic and Pretreatment EBV-DNA Virus Load in Stage II Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy with Concurrent CisplatinLi Hua, Shaojun Chen, Mengzhuan Wei, et al.Cancer Biotherapy & Radiopharmaceuticals|September 10, 2011
The use of ¹²⁵I seed strands for intraluminal brachytherapy of malignant obstructive jaundiceYi Chen, Xiao-Lin Wang, Zhi-Ping Yan, et al.Cancer Biotherapy & Radiopharmaceuticals|February 10, 2012
Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killingSofia R Gameiro, Jorge A Caballero, James W HodgeCancer Biotherapy & Radiopharmaceuticals|January 31, 2012
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenograftsHongju Wu, Yan Xin, Yuping Xiao, et al.Cancer Biotherapy & Radiopharmaceuticals|January 31, 2012
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetanMarco D'Arienzo, Francesco Cicone, Laura Chiacchiararelli, et al.Cancer Biotherapy & Radiopharmaceuticals|September 29, 2011
Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment responseSeda Lacin, Ilker Oz, Elgin Ozkan, et al.Pageof 223